Merck | MRK - Operating Profit


Merck reported EUR474M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Adidas EUR 164M 572M Dec/2025
Adyen EUR 482.78M 31.18M Jun/2025
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 313M 19M Dec/2025
Amadeus IT EUR 338.9M 142.6M Dec/2025
Amarin USD -2.26M 564K Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR -175M 668M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Beiersdorf EUR 504M 312M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Danone EUR 1.81B 249M Jun/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 260M 199M Dec/2025
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Henkel EUR 1.42B 187M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Infineon EUR 388M 150M Dec/2025
Linde USD 2.25B 160M Dec/2025
Lonza CHF 673M 243M Jun/2025
Merck EUR 474M 738M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1.29B 571M Dec/2025